Back to Search
Start Over
Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin
- Source :
- European Journal of Clinical Pharmacology, 74(1), 139-140. Springer Verlag, Smit, R, van Marum, R J, Péquériaux, N C, Hollander, D A, Bleeker, M W P, Latify, Y, Hermens, W A & Derijks, H J 2018, ' Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin ', European Journal of Clinical Pharmacology, vol. 74, no. 1, pp. 139-140 . https://doi.org/10.1007/s00228-017-2339-7
- Publication Year :
- 2017
- Subjects :
- Pharmacology
Male
medicine.medical_specialty
business.industry
Pharmacology toxicology
Anticoagulants
Nadroparin
General Medicine
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Text mining
Internal medicine
Factor Xa
medicine
Humans
Pharmacology (medical)
Female
030212 general & internal medicine
Renal Insufficiency
business
Aged
Glomerular Filtration Rate
Subjects
Details
- ISSN :
- 14321041 and 00316970
- Volume :
- 74
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- European journal of clinical pharmacology
- Accession number :
- edsair.doi.dedup.....4f1152168ebe86a3e4c68e761d461525